CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction Red Cell Distribution Width in Patients with Diabetes and Myocardial Infarction: an analysis from the EXAMINE trial Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial Association of Silent Myocardial Infarction and Sudden Cardiac Death Characterization of lesions undergoing ischemia-driven revascularization after complete revascularization versus culprit lesion only in patients with STEMI and multivessel disease - A DANAMI-3-PRIMULTI substudy Cardiopulmonary Exercise Testing: What Is its Value? Early versus delayed invasive intervention in acute coronary syndromes Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction Early Natural History of Spontaneous Coronary Artery Dissection Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial

Clinical Trial2020 Nov 11.

JOURNAL:Circulation. Article Link

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

SD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al. Keywords: cardiorenal outcomes; empagliflozin

Full Text PDF